Researches

South Egypt Cancer Institute

Assiut University

# Title Department Research Member Research Year
141 Role of serum miR-21 and miR-92a in colorectal cancer diagnosis as novel molecular biomarkers Department of Surgical Oncology Mohamed Ismail Omar Ali 2021
142 Clinicopathological features of relapsed diffuse large B-cell
lymphoma: South Egypt Cancer Institute experience
 		Department of Pathology Saly Salah Abdelhakeem 2021
143 Feasibility of dual-phase 99mTc-MDP SPECT/CT imaging in rheumatoid arthritis evaluation Department of Radiotherapy and Nuclear medicine Dr. Yasser Gaber Ali Abdelhafez 2021
144 Pattern of Pediatric Soft Tissue and Bone Sarcomas at South
Egypt Cancer Institute, Retrospective Study 		Department of Pathology Dr. Tarek Mohamed Abdel Moneim Mohamed Elsaba Ahmed 2021
145 Higher proportion of non-classical and intermediate monocytes in newly diagnosed multiple myeloma patients in Egypt: a possible prognostic marker
 		Department of Medical Oncology Dr. Hanaan Ahmed Mohammed Ahmed 2021
146 Role of post-therapy 99mTc-MIBI single-photon emission computed tomography/computed tomography scan in predicting survival in patients with high-grade glioma Department of Radiotherapy and Nuclear medicine Dr. Haisam Ahmed Samy Aly Atta 2021
147 Long term survival outcome of childhood acute lymphoblastic leukemia treated with modified TXIIIB protocol at South Egypt Cancer Institute Department of Pediatric Oncology Prof. Heba Abdel-Razik Sayed Hussein 2021
148 Concurrent capecitabine with external beam radiotherapy versus radiotherapy alone in painful bone metastasis of breast cancer origin Department of Radiotherapy and Nuclear medicine Dr. Ayat allah Ali yousseif 2021
149 Concurrent capecitabine with external beam radiotherapy versus radiotherapy alone in painful bone metastasis of breast cancer origin Department of Anesthesia, Intensive care and Pain management Dr. Shereen Mamdoh Mohamed kamal 2021
150 Ewing sarcoma outcomes in a country with limited resources: Egypt as an example Department of Medical Oncology Dr. Ahmed Mubarak Hefni Ismail 2021